Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
dimanche, octobre 25
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Achieve Life Sciences Inc
ACHV
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$6.49
-0.01
-0.15%
Dern. MÀJ: Oct 23, 4:00 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Achieve Life Sciences Financials
Achieve Life Sciences (ACHV) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Achieve Life Sciences Q2 EPS $(0.80) Misses $(0.16) Estimate
Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.16) by 400 percent. This is a 116.22 percent decrease over losses of $(0.37) per
Benzinga Newsdesk
PRO
Achieve Life Sciences Q1 EPS $(0.19) Beats $(0.30) Estimate
Benzinga Newsdesk
Earnings Scheduled For May 12, 2026
Benzinga Insights
PRO
Achieve Life Sciences Q4 EPS $(0.28) Misses $(0.27) Estimate
Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.27) by 5.26 percent. This is a 22.22 percent increase over losses of $(0.36) per share
Benzinga Newsdesk
Earnings Scheduled For March 24, 2026
Benzinga Insights
PRO
Achieve Life Sciences Q3 EPS $(0.28) Misses $(0.26) Estimate
Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.26) by 8.95 percent. This is a 22.22 percent increase over losses of $(0.36) per share
Benzinga Newsdesk
